ZOYAFER-FCM
MRP: 2,700
Packaging: 50mg/10ml
Pack Type: injection
Composition:
Ferric Carboxymaltose Injection 50mg/ml
Indication:
for the treatment of iron deficiency anemia in adults, particularly when oral iron therapy is ineffective or not tolerated. It is commonly used in patients with chronic kidney disease, postpartum anemia, or perioperative anemia to rapidly replenish iron stores through intravenous administration.
Description:
Ferric Carboxymaltose – 50 mg/ml
This is an intravenous (IV) iron replacement therapy used primarily in patients with iron deficiency anemia, particularly when oral iron is ineffective or cannot be used.
Tags:
- Rapid iron replenishment
- Suitable for patients intolerant to oral iron
- Reduces fatigue and symptoms of anemia
- Requires fewer doses than oral iron therapy
- Improves hemoglobin and ferritin levels effectively
Usage Information
Dosage
Adults: Typically, a single dose of up to 1000 mg iron (up to 20 ml) can be given by slow IV injection or infusion. Frequency: Based on hemoglobin and iron stores; may be repeated after 1 week if necessary. Administer under the supervision of a qualified healthcare provider only.
Side Effects
Common side effects may include: Headache Dizziness Nausea Injection site reactions (pain, swelling) Low blood phosphate levels (hypophosphatemia) Rare but serious: Allergic reactions Hypertension during/after administration
Contraindications
Known hypersensitivity to ferric carboxymaltose or excipients Iron overload disorders (e.g., hemochromatosis) Anemia not caused by iron deficiency First trimester of pregnancy (unless absolutely necessary)